Botfet / Company detail

GSK

approved

GSK plc

biotech

Moat score66out of 100

The numbers

Financial metrics

Quality gate and thesis context

Roic16.6%

Gross Margin72.4%

Revenue Cagr7.2%

Fcf Conversion101.9%

Fcf YieldNot available: currency mismatch

Interest Coverage15.1x

Market Cap B$102.2B

Pe15.8

Quality PassPass

Founder LedNo

Thesis AlignedYes

Moat Quant66

Why it may endure

Moat breakdown

Quant: 66 · Curator: 0

Market Share Stability18

Network Effects6

Pricing Power20

Regulatory Moat16

Switching Costs6

Conviction0/10

Leadership0/10

Vision0/10

← Back to the full screener